MRC Technology Appoints Two New Members to Board of Trustees
News Apr 07, 2016
MRC Technology aims to find new treatments in areas where there is unmet patient need. It works with academic, biotechnology, pharmaceutical and charity organisations to find science with potential and develop it to improve diagnostics and medicines. Current board members have been selected for their extensive experience across the biomedical sciences, finance, investment fund management, law and medicine, in order to support strategic direction and delivery of the organisation’s charitable objects.
Dr John Stageman, Chairman, MRC Technology, commented: “As a charity we strive to ensure that innovative science in any disease area reaches its full potential. Our board of trustees plays a vital role in governing the charity and we are therefore delighted to welcome Les and Mike who together bring huge additional experience in life sciences research and development, and related industry knowledge.”
Dr Les Hughes’ experience in the pharmaceutical industry spans over 30 years, initially as a medicinal chemist followed by roles leading drug discovery projects and programmes across a number of therapeutic areas. He was elected a Fellow of the Academy of Medical Sciences in 2003.
Dr Mike Romanos has been involved in the biotech and pharmaceutical industry for over 30 years, with experience covering most areas of drug discovery science and technology, and several therapeutic areas, as well as experience in shaping IP strategy and gaining and defending valuable patents.
Disease-Fighting 'Warheads' Hidden in BacteriaNews
Bacteria found in soil may harbor a potential game-changer for drug design. A new study by Scripps Research, published today in Nature Communications, suggests scientists could build better drugs by learning from bacteria-derived molecules called thiocarboxylic acids.READ MORE
Exploring Challenges in the Synthesis of Pharmaceutical DrugsNews
This summer, Wendell and Loretta Hess Professor of Chemistry Ram Mohan will travel to India and Hong Kong to deliver a series of post-graduate workshops on advanced concepts in organic synthesis.
His workshop “Advanced Concepts in the Synthesis of Pharmaceutical Drugs” at the Indian Institute of Technology Indore will explore the unique, real-world challenges in the pharmaceutical industry to synthesize drugs that are both commercially viable and eco-friendly.
Modern Alchemists are Making Chemistry GreenerNews
Ancient alchemists tried to turn lead and other common metals into gold and platinum. Modern chemists in Paul Chirik’s lab at Princeton are transforming reactions that have depended on environmentally unfriendly precious metals, finding cheaper and greener alternatives to replace platinum, rhodium and other precious metals in drug production and other reactions.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018